Clinical trial
Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy
NCT03889756 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy
- Lead sponsor
- Yale University
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- July 17, 2019
- Completion date
- January 5, 2023
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.